日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum

贝伐珠单抗联合化疗治疗直肠癌直至手术(BACCHUS):一项II期、多中心、开放标签、随机研究,旨在评估新辅助化疗单独用于高危直肠癌患者的疗效

Glynne-Jones, R; Hava, N; Goh, V; Bosompem, S; Bridgewater, J; Chau, I; Gaya, A; Wasan, H; Moran, B; Melcher, L; MacDonald, A; Osborne, M; Beare, S; Jitlal, M; Lopes, A; Hall, M; West, N; Quirke, P; Wong, Wai-Lup; Harrison, M

Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide.

对两项肺癌 III 期临床试验中接受单纯化疗或化疗联合沙利度胺治疗的患者进行循环血管生成生物标志物分析

Young R J, Tin A W, Brown N J, Jitlal M, Lee S M, Woll P J